Rankings
▼
Calendar
BEAM Q2 2024 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
BEAM
Beam Therapeutics Inc.
$3B
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$12M
-41.5% YoY
Gross Profit
$12M
100.0% margin
Operating Income
-$105M
-891.1% margin
Net Income
-$91M
-773.5% margin
EPS (Diluted)
$-1.11
QoQ Revenue Growth
+58.9%
Cash Flow
Operating Cash Flow
-$83M
Free Cash Flow
-$85M
Stock-Based Comp.
$32M
Balance Sheet
Total Assets
$1.3B
Total Liabilities
$407M
Stockholders' Equity
$854M
Cash & Equivalents
$293M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$12M
$20M
-41.5%
Gross Profit
$12M
-$77M
+115.2%
Operating Income
-$105M
-$102M
-2.7%
Net Income
-$91M
-$83M
-10.0%
← FY 2024
All Quarters
Q3 2024 →